ArticleNature medicine2021
Toward superhuman SARS-CoV-2 immunity?
Article in Nature medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- COVID-19 and plasma cells: Is there long-lived protection?Immunological reviews · 2022Review
- Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2.Frontiers in immunology · 2022Review
- Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.Frontiers in pharmacology · 2022Article
- Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.Biomedicines · 2021Review
- COVID-19 related interdisciplinary methods: Preventing errors and detecting research opportunities.Methods (San Diego, Calif.) · 2021Review
- Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening.Scientific reports · 2021Article
- Has SARS-CoV-2 reached peak fitness?Nature medicine · 2021Article
- Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.Nature reviews. Immunology · 2021Review
- Guidelines for Reopening a Nation in a SARS-CoV-2 Pandemic: A Path Forward.Medicina (Kaunas, Lithuania) · 2021Article
- Emergent human coronaviruses - History informs the future.Journal of virological methods · 2021Article
- Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand.Clinical & translational immunology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
33257892What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.